Sin-Ching Chiu
Family Medicine · Toledo, OHNPI 1205814472
Payments from drug & device makers
Across 73 payments — averaging $23.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$268
- Novo Nordisk$197
- AstraZeneca$189
- AbbVie$170
- Indivior Inc.$153
- Lilly USA, LLC$144
- plus $628 from 14 others
What the payments were for
- Food & beverage$1,748100%
- Education$10%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 13 | $268 |
| Novo Nordisk | 10 | $197 |
| AstraZeneca | 3 | $189 |
| AbbVie | 5 | $170 |
| Indivior Inc. | 5 | $153 |
| Lilly USA, LLC | 8 | $144 |
| Gilead | 2 | $119 |
| Exact Sciences | 6 | $96 |
| Pfizer | 5 | $94 |
| Braeburn Inc. | 3 | $58 |
| Alkermes, Inc. | 2 | $51 |
| Viatris Specialty LLC | 2 | $38 |
| Regeneron Healthcare Solutions, Inc. | 2 | $37 |
| Mylan Specialty L.p. | 1 | $30 |
| Axsome Therapeutics, Inc. | 1 | $21 |
| Corcept Therapeutics | 1 | $20 |
| Teva Pharmaceuticals USA, Inc. | 1 | $19 |
| Actelion Pharmaceuticals US, Inc. | 1 | $16 |
| Otsuka America Pharmaceutical, Inc. | 1 | $15 |
| Amgen | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,748 in reported general payments places this provider in the 70th percentile of 3,983 family medicine providers in Ohio.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 127 | $157,020 |
| JanuviaSitagliptin Phosphate | 63 | $73,916 |
| EliquisApixaban | 55 | $62,712 |
| FarxigaDapagliflozin Propanediol | 36 | $40,332 |
| OzempicSemaglutide | 32 | $35,445 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 34 | $27,342 |
| TrulicityDulaglutide | 19 | $24,448 |
| MounjaroTirzepatide | 11 | $14,130 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 21 | $11,609 |
| LinzessLinaclotide | 17 | $9,140 |
| EntrestoSacubitril/Valsartan | 11 | $8,407 |
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 64 | $6,685 |
| SymbicortBudesonide/Formoterol Fumarate | 16 | $6,248 |
| Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate | 25 | $5,586 |
| VascepaIcosapent Ethyl | 19 | $5,229 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $94 | $62,71255 claims |
| AstraZenecaFarxiga, Breztri Aerosphere, Symbicort | $189 | $58,19073 claims |
| Lilly USA, LLCTrulicity, Mounjaro | $144 | $38,57830 claims |
| Novo NordiskOzempic | $197 | $35,44532 claims |
| AbbVieLinzess | $170 | $9,14017 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 3,983 family medicine providers in Ohio.
Other family medicine in Toledo
- Henry NaddafToledo$252K
- Michael ButcherCincinnati$18.3M
- William RandallKettering$7.5M
- Paul NugentCincinnati$4.9M
- Steve ChoiDayton$4.8M
- Martin SchearDayton$2.2M
- Rajesh DavitCincinnati$2M
- Kwabena OtengSpringdale$2M
- Blaise GattoMoraine$1.8M
- Cathy GreiweColumbus$1.4M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.